Specifications
- Purity
- ≥99% (HPLC)
- Appearance
- White or slightly yellow, fine powder
- Identity
- 1H-NMR
Properties
- Solvents
- DMSO (10 mg/ml), water (insoluble)
Categories:
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
Nonselective NMDA and AMPA glutamate receptor antagonist. A class B calcium-channel-blocker, antiglutamatergic agent and shown to act as an antioxidant.
Synonyms | 1-[2-(Diethylamino)ethyl]-3-[(4-methoxyphenyl)methyl]-2(1H)-quinoxalinone monohydrochloride, P 201-1 |
---|---|
Purity | ≥99% (HPLC) |
Appearance | White or slightly yellow, fine powder |
CAS-Number | 55750-05-5 |
Molecular Formula | C22H27N3O2.HCl.H2O |
Molecular Weight | 401.93 |
Identity | 1H-NMR |
Solvents | DMSO (10 mg/ml), water (insoluble) |
Smiles | O=C1C(CC2=CC=C(OC)C=C2)=NC3=CC=CC=C3N1CC[NH+](CC)CC.[Cl-] |
InChi Key | JRNWTJUIMRLKBV-UHFFFAOYSA-N |
Shipping | AMBIENT |
Short Term Storage | RT |
Long Term Storage | +4°C |
Handling Advice | Protect from light and moisture. |
Use / Stability | Stable for at least 2 years after receipt when stored at +4°C. |
Hazard statements | H302 |
Precautionary statements | P264, P270, P301+P312, P330, P501 |
GHS Symbol | GHS07 |
Signal word | Warning |
Transportation | Not dangerous goods |
References | (1) K. Ehrenberger & D. Felix, Acta Otolaryngol. 115, 236 (1995), (2) C. Geretsegger & R. Fartacek, Eur. Neuropsychopharmacol. 8, 191 (1998), (3) N. Udilova, et al., Biochem. Pharmacol. 65, 59 (2003), (4) G.B. Feld, et al., Neuropsychopharmacol. 38, 2688 (2013) |
Quantity | 25 mg, 100 mg, Bulk |